A detailed history of Mirova transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mirova holds 6,987 shares of MRK stock, worth $720,499. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,987
Previous 6,987 -0.0%
Holding current value
$720,499
Previous $864,000 8.22%
% of portfolio
0.14%
Previous 0.16%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $644,998 - $692,721
5,210 Added 293.19%
6,987 $864,000
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $10,819 - $11,774
-108 Reduced 5.73%
1,777 $193,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $517,632 - $574,851
-5,028 Reduced 72.73%
1,885 $194,000
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $930,244 - $1.01 Million
-8,565 Reduced 55.34%
6,913 $797,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $21,205 - $23,661
-206 Reduced 1.31%
15,478 $1.65 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $140,253 - $179,824
1,604 Added 11.39%
15,684 $1.74 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $204,647 - $229,898
-2,421 Reduced 14.67%
14,080 $1.21 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $144,103 - $163,348
1,726 Added 11.68%
16,501 $1.5 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $17,936 - $20,105
-244 Reduced 1.62%
14,775 $1.21 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $1.63 Million - $2.04 Million
-22,558 Reduced 60.03%
15,019 $1.15 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $244,715 - $269,125
3,414 Added 9.99%
37,577 $2.82 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $106,449 - $117,743
1,514 Added 4.64%
34,163 $2.66 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $323,159 - $380,649
4,693 Added 16.79%
32,649 $2.52 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $1.83 Million - $2.03 Million
25,489 Added 1033.2%
27,956 $2.29 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $51,884 - $58,811
-709 Reduced 22.32%
2,467 $205,000
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $4,577 - $5,208
-65 Reduced 2.01%
3,176 $246,000
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $84,268 - $116,800
-1,330 Reduced 29.1%
3,241 $249,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $134,213 - $151,444
1,730 Added 60.89%
4,571 $416,000
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $19,476 - $21,230
256 Added 9.9%
2,841 $239,000
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $53,646 - $61,186
771 Added 42.5%
2,585 $215,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $118,345 - $137,337
1,814 New
1,814 $139,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mirova Portfolio

Follow Mirova and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.